when to switch from semaglutide to tirzepatide Switching Guide In 2026 Can You Switch From Semaglutide

A 2024 Swedish study followed 3,249 MS patients for an average of 10.6 years and found that obesity was associated with: 4 43% higher risk of reaching EDSS 3 (moderate disability) 40% higher risk of reaching EDSS 4 (significant walking impairment) More rapid cognitive decline Higher MRI activity showing new brain lesions A German study of 1,066 MS patients found that obese patients reached disability milestones more quickly than those with normal weight

Options include gradually reducing or stretching out your doses

Telehealth providers must be licensed in Washington state to prescribe medications to residents

Kidney function: Reduced kidney function may slow down the drugs clearance